In addition, weight loss is associated with a reduction in resting energy expenditure due to changes in body composition, so-called metabolic adaptation, which has also been shown to be associated with weight regain [47]
Ongoing Monitoring and Support We provide continued follow-up to monitor progress, ensure safety, and optimize outcomes
Nature Reviews, 2014
van Ruiten CC, Veltman DJ, Schrantee A, van Bloemendaal L, Barkhof F, Kramer MHH et al (2022) Effects of dapagliflozin and combination therapy with exenatide on food-cue induced brain activation in patients With type 2 diabetes
Here we found that KL1 alone did not induce bacterial outgrowth in the liver, spleen or kidneys, indicating that it did not compromise host immune control over the infection (Extended Data Fig
The announcement is expected to bouy GLP-1 pharmaceutical manufacturers ambitions to list their medicines on Australias Pharmaceutical Benefits Scheme (PBS) for use for obesity weight management
